Lexaria Bioscience
LEXX
LEXX
25 hedge funds and large institutions have $3.23M invested in Lexaria Bioscience in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.62% less ownership
Funds ownership: 11.63% → 7.01% (-4.6%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$166K | |
| 2 | +$144K | |
| 3 | +$143K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$141K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$90.8K |
Top Sellers
| 1 | -$939K | |
| 2 | -$320K | |
| 3 | -$75K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$49.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.3K |